Your browser doesn't support javascript.
loading
IP-10 and MIG are sensitive markers of early virological response to HIV-1 integrase inhibitors.
Álvarez, Hortensia; Gutiérrez-Valencia, Alicia; Mariño, Ana; Saborido-Alconchel, Abraham; Calderón-Cruz, Beatriz; Pérez-González, Alexandre; Alonso-Domínguez, Jacobo; Martínez-Barros, Inés; Gallego-Rodríguez, María; Moreno, Santiago; Aldamiz, Teresa; Montero-Alonso, Marta; Bernal, Enrique; Galera, Carlos; Llibre, Josep M; Poveda, Eva.
Afiliación
  • Álvarez H; Infectious Diseases Unit, Department of Internal Medicine, Complexo Hospitalario Universitario de Ferrol, Servicio Galego de Saúde (SERGAS)-A Coruña, A Coruña, Spain.
  • Gutiérrez-Valencia A; Department of Biochemistry, Genetics and Immunology, Universidade de Vigo, Vigo, Spain.
  • Mariño A; Clinical Unit of Infectious Diseases and Microbiology, Institute of Biomedicine of Seville (IBiS), Virgen del Rocío University Hospital, Spanish National Research Council (CSIC), University of Seville, Seville, Spain.
  • Saborido-Alconchel A; Infectious Diseases Unit, Department of Internal Medicine, Complexo Hospitalario Universitario de Ferrol, Servicio Galego de Saúde (SERGAS)-A Coruña, A Coruña, Spain.
  • Calderón-Cruz B; Clinical Unit of Infectious Diseases and Microbiology, Institute of Biomedicine of Seville (IBiS), Virgen del Rocío University Hospital, Spanish National Research Council (CSIC), University of Seville, Seville, Spain.
  • Pérez-González A; Galicia Sur Health Research Institute (IIS Galicia Sur)-Complexo Hospitalario Universitario de Vigo, Servicio Galego de Saúde-Universidade de Vigo (SERGAS-U, Vigo), Vigo, Spain.
  • Alonso-Domínguez J; Galicia Sur Health Research Institute (IIS Galicia Sur)-Complexo Hospitalario Universitario de Vigo, Servicio Galego de Saúde-Universidade de Vigo (SERGAS-U, Vigo), Vigo, Spain.
  • Martínez-Barros I; Galicia Sur Health Research Institute (IIS Galicia Sur)-Complexo Hospitalario Universitario de Vigo, Servicio Galego de Saúde-Universidade de Vigo (SERGAS-U, Vigo), Vigo, Spain.
  • Gallego-Rodríguez M; Galicia Sur Health Research Institute (IIS Galicia Sur)-Complexo Hospitalario Universitario de Vigo, Servicio Galego de Saúde-Universidade de Vigo (SERGAS-U, Vigo), Vigo, Spain.
  • Moreno S; Galicia Sur Health Research Institute (IIS Galicia Sur)-Complexo Hospitalario Universitario de Vigo, Servicio Galego de Saúde-Universidade de Vigo (SERGAS-U, Vigo), Vigo, Spain.
  • Aldamiz T; Infectious Diseases Department, Hospital Universitario Ramón y Cajal, Madrid, Spain.
  • Montero-Alonso M; Infectious Diseases Unit, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
  • Bernal E; Infectious Diseases Unit, Hospital Universitario y Politécnico La Fe, Valencia, Spain.
  • Galera C; Infectious Diseases Unit, Hospital General Universitario Reina Sofía, Murcia, Spain.
  • Llibre JM; Internal Medicine Department, Hospital Universitario Virgen de la Arrixaca, Murcia, Spain.
  • Poveda E; Infectious Diseases Division and Fight Infections Foundation, University Hospital Germans Trias i Pujol, Badalona, Barcelona, Spain.
Front Immunol ; 14: 1257725, 2023.
Article en En | MEDLINE | ID: mdl-37920466
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: VIH-1 / Inhibidores de Integrasa VIH Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: VIH-1 / Inhibidores de Integrasa VIH Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article